Congenital myopathies in the new millennium

Journal of Child Neurology

Volumn 20, Issue 2, 2005, Pages 94-101

  Goebel, Hans H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); ALPHA CRYSTALLIN; DESMIN; GENE PRODUCT; GLIAL FIBRILLARY ACIDIC PROTEIN; MYOSIN; MYOTUBULARIN; PROTEIN; RYANODINE RECEPTOR; SELENOPROTEIN; UNCLASSIFIED DRUG;

ACTA1 GENE; ACTINOPATHY; ALPHA B CRYSTALLINOPATHY; ARTICLE; CENTRAL CORE DISEASE; CENTRONUCLEAR MYOPATHY; DESMINOPATHY; DISEASE CLASSIFICATION; GENE; GENE LOCUS; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; MTM1 GENE; MULTIMINICORE DISEASE; MUSCLE CELL; MUSCULAR DYSTROPHY; MYH7 GENE; MYOPATHY; MYOSINOPATHY; MYOTILINOPATHY; NEMALINE MYOPATHY; PRIORITY JOURNAL; PROTEIN AGGREGATION; RYR1 GENE; SELENOPROTEINOPATHY;

EID: 16844386077     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200020201     Document Type: Article

References (61)

1. Shy GM, Magee KR: A new congenital non-progressive myopathy. Brain 1956;79:610-621.
2. Goebel HH: Congenital myopathies at their molecular dawning. Muscle Nerve 2003;7:527-548.
3. Sewry C. Marinesco-Sjögren syndrome, in Karpati G (ed): Structural and Molecular Basis of Skeletal Muscle Diseases. Lawrence, KS, Allen Press, 2002, 277-278.
4. Manzur AY, Sewry CA, Zirpin J, et al: A severe clinical and pathological variant of central core disease with possible autosomal recessive inheritance. Neuromuscul Disord 1998;8:467-473.
5. Ferreiro A, Estournet B, Chateau D, et al: Multi-minicore disease - Searching for boundaries: Phenotype analysis of 38 cases. Ann Neurol 2000;48:745-757.
6. Kaindl AM, Krause S, Rüschendorf F, et al: Missense mutations of ACTA1 cause dominant congenital myopathy with cores, abstract. Neuromuscul Disord 2004;14:562.
7. Vita G, Migliorato A, Baradello A, et al: Expression of cytoskeletal proteins in central core disease. J Child Neurol 1994;124:71-76.
8. Parain K, Herasse M, Monnier N, et al: Proteins implicated in Ca2+ homeostasis: Expression patterns in genetically characterized core myopathies, abstract. Neuromuscul Disord 2004;14:588.
9. De Bleecker JL, Ertl BB, Engel AG: Patterns of abnormal protein expression in target formations and unstructured cores. Neuromuscul Disord 1996;6:339-349.
10. Bönnemann C, Thompson TG, van der Ven PFM, et al: Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle. J Neurol Sci 2003;206:71-78.
11. Ferreiro A, Monnier N, Romero NB, et al: A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ann Neurol 2002;51:750-759.
12. Ferreiro A, Ceuterick-de Groote C, Marks JJ, et al: Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol 2004;55:676-686.
13. Goebel HH, Piirsoo A, Warlo I, et al: Infantile intranuclear rod myopathy. J Child Neurol 1997;12:22-30.
14. Wallgren-Pettersson C, Pelin K, Nowak KJ, et al: Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle α-actin. Neuromuscul Disord 2004;14:461-470.
15. Ohlsson M, Tajsharghi H, Darin N, et al: Follow-up of nemaline myopathy in two patients with novel mutations in the skeletal muscle α-actin gene (ACTA1). Neuromuscul Disord 2004; 14:471-475.
16. Agrawal PB, Strickland CD, Midgett C, et al: Heterogeneity of nemaline myopathy cases with skeletal muscle α-actin gene mutations. Ann Neurol 2004;56:86-96.
17. Sewry CA, Rodillo E, Heckmatt JZ, Dubowitz V: Immunocytochemical studies of congenital centronuclear and nemaline myopathies, abstract. J Neurol Sci 1990;98(Suppl):100.
18. Goebel HH, Warlo I: Nemaline myopathy with intranuclear rods - Intranuclear rod myopathy. Neuromuscul Disord 1997;7:13-19.
19. Nowak K, Wattanasirichaigoon D, Goebel HH, et al: Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet 1999;23:208-212.
20. Monnier N, Romero NB, Lerale J, et al: An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanoline receptor. Hum Mol Genet 2000;9:2599-2608.
21. Scacheri PC, Hoffman EP, Fratkin JD, et al: A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology 2000;55:1689-1696.
22. Dubowitz V: Muscle Biopsy: A Practical Approach. London, Baillière Tindall, 1985, 664-670.
23. Karpati G, Carpenter S: Skeletal muscle in neuromuscular diseases, in Rowland LP, DiMauro S (eds): Myopathies - Handbook of Clinical Neurology, vol 18. Amsterdam, Elsevier Science Publishers BV, 1992, 1-48.
24. Cancilla PA, Kalyanaraman K, Verity MA, et al: Familial myopathy with probable lysis of myofibrils in type I fibres. Neurology 1971;21:579-585.
25. Nucci A, Queiroz LS: A sporadic case of hyaline body myopathy, abstract. Neuromuscul Disord 2004;14:566.
26. Ceuterick C, Martin J-J, Martens C: Hyaline bodies in skeletal muscle of a patient with a mild chronic nonprogressive congenital myopathy. Clin Neuropathol 1993;12:79-83.
27. Masuzugawa S, Kuzuhara S, Narita Y, et al: Autosomal dominant hyaline body myopathy presenting as scapuloperoneal syndrome: Clinical features and muscle pathology. Neurology 1997;48:253-257.
28. Tajsharghi H, Thornell L-E, Lindberg C, et al: Myosin storage myopathy associated with a heterozygous missense mutation in MYH7. Ann Neurol 2003;54:494-500.
29. Bohlega S, Abu-Amero SN, Wakil SM, et al: Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy. Neurology 2004;62:1518-1521.
30. Goebel HH, Fardeau M: Familial desmin-related myopathies and cardiomyopathies - From myopathology to molecular and clinical genetics. 36th European Neuromuscular Centre (ENMC)-Sponsored International Workshop, 20-22 October 1995, Naarden, The Netherlands. Neuromuscul Disord 1996;6:383-388.
31. Goebel HH, Warlo IAP: Progress in desmin-related myopathies. J Child Neurol 2000;15:565-572.
32. Engel AG: Myofibrillar myopathy, editorial. Ann Neurol 1999; 46:681-683.
33. Goldfarb LG, Park K-Y, Cervenḱová S, et al: Missense mutations in desmin associated with familial cardiac and skeletal myopathy, letter. Nat Genet 1998;19:402-403.
34. Goldfarb LG, Vicart P, Goebel HH, Dalakas MC: Desmin myopathy. Brain 2004;127:723-734.
35. Goebel HH, Schloon H, Lenard HG: Congenital myopathy with cytoplasmic bodies. Neuropediatrics 1981;12:166-180.
36. Goebel HH, Muller J, Gillen HW, Merritt, AD: Autosomal dominant "spheroid body myopathy." Muscle Nerve 1978; 1:14-26.
37. Fardeau M, Godet-Guillain J, Tomé FSM, et al: Une nouvelle affection musculaire familiale, définie par l'accumulation intra-sarco-plasmique d'un matériel granulo-filamentaire dense en microscopie électronique. Rev Neurol (Paris) 1978; 134:411-425.
38. Osborn M, Goebel HH: The cytoplasmic bodies in a congenital myopathy can be stained with antibodies to desmin, the muscle-specific intermediate filament protein. Acta Neuropathol (Berl) 1983;62:149-152.
39. Goebel HH, Voit T, Warlo I, et al: Immunohistologic and electron microscopic abnormalities of desmin and dystrophin in familial cardiomyopathy and myopathy. Rev Neurol (Paris) 1994;150:452-459.
40. Goebel HH, Anderson JR, Hübner C, et al: Congenital myopathy with excess of thin myofilaments. Neuromuscul Disord 1997;7:160-168.
41. Fardeau M, Vicart F, Caron A, et al: Myopathie familiale avec surcharge en desmine, sous forme de matériel granulo-filamentaire dense en microscopie électronique, avec mutation dans le gène de l'alpha-B-cristalline. Rev Neurol (Paris) 2000; 156:497-504.
42. Pica EC, Pramono ZAD, Lai PS, Yee WC: A novel desmin mutation S13F in a case of spheroid body myopathy with desmin storage, abstract. Neuromuscul Disord 2004;14:565.
43. Goebel HH, Borchert A: Protein surplus myopathies and other rare congenital myopathies. Semin Pediatr Neurol 2002;9:160-170.
44. Vicart P, Caron A, Guicheney P, et al: A missense mutation in the alpha-B crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 1998;20:92-95.
45. Selcen D, Engel AG: Myofibrillar myopathy caused by novel dominant negative αB-crystallin mutations. Ann Neurol 2003;54:804-810.
46. Selcen D, Engel AG: Mutations in myotilin cause myofibrillar myopathy. Neurology 2004;62:1363-1371.
47. De Bleecker JL, Engel AG, Ertl BB: Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 1996;55:563-577.
48. Ferrer I, Martín B, Castaño JG, et al: Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 2004;63:484-498.
49. Goebel HH, Halbig LE, Goldfarb L, et al: Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: A mixed congenital myopathy. Neuropediatrics 2001;32:196-205.
50. Kiyomoto BH, Murakami N, Kobayashi Y, et al: Fatal reducing body myopathy: Ultrastructural and immunohistochemical observations. J Neurol Sci 1995;128:58-65.
51. Liewluck T, Ohsawa M, Sasaki M, et al: ER stress-mediated apoptosis in autosomal dominant reducing body myopathy, abstract. Neuromuscul Disord 2004;14:588-589.
52. Rapuzzi S, Prelle A, Moggio M, et al: High serum creatine kinase levels associated with cylindrical spirals at muscle biopsy. Acta Neuropathol (Berl) 1995;90:660-664.
53. Biancalana V, Caron O, Gallati S, et al: Characterization of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet 2003;112:135-142.
54. Tsai TC, Horinouchi H, Noguchi S, et al: Characterization of MTM1 mutations in 32 Japanese patients with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism, abstract. Neuromuscul Disord 2004;14:589.
55. Buj-Bello A, Laporte J, Mandel JL: A novel antibody for rapid diagnosis of X-linked myotubular myopathy by immunodetection of myotubularin, abstract G.P.8.06. Neuromuscul Disord 2004;14:589.
56. Jeannet PY, Bassez G, Eymard B, et al: Clinical and histologic findings in autosomal centronuclear myopathy. Neurology 2004;62:1484-1490.
57. Tiret L, Blot S, Kessler JL, et al: The CNM locus, a canine homologue of human autosomal forms of centronuclear myopathy, maps to chromosome 2. Hum Genet 2003;113:297-306.
58. Clarke NF, Laing NB, Walker KR, et al: The genetic basis and clinical features of congenital fibre type disproportion, abstract. Neuromuscul Disord 2004;14:588.
59. Schröder JM: Congenital fiber type disproportion, in Lane RJM (ed): Handbook of Muscle Disease. New York, Marcel Dekker, 1996, 195-200.
60. Vorwerk G, Christoffersen CT, Muller J, et al: Alternative splicing of exon 17 and a missense mutation in exon 20 of the insulin receptor gene in two brothers with a novel syndrome of insulin resistance (congenital fiber-type disproportion myopathy). Horm Res 1999;52:211-220.
61. Sharma MC, Sarkar C, Gulati S, Singh S: Congenital myopathy - A clinicopathological study of 11 cases: An Indian experience, abstract. Neuromuscul Disord 2004;14:591.